Investing Profile

David Ebsworth

InvestorAngel
Chairman Of The Supervisory Board at Synlab AG
Photo of David Ebsworth, Angel

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Angel
$5K - $50K
$25K
2
CompanyStageDateRound SizeTotal Raised
Verona Pharma
Post Ipo EquityJul 2020$200M
$200M
Small Pharma
SeedApr 2017$1M
$1M
£830K
Co-investors: Ken Belotsky (Negev Capital), Peter Keen